2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Updates on HER2-Directed ADCs Across Solid Tumors - Episode 16
Key opinion leaders examine promising antibody-drug conjugates (ADCs) in the pharmaceutical development pipeline.
Related Content: